Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel · Delayed Price · Currency is ILS · Price in ILA 315.50
-12.90 (-3.93%)
Nov 19, 2025, 5:24 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 77.99 million as of November 19, 2025. Its market cap has decreased by -27.89% in one year.
Market Cap
77.99M
Enterprise Value
18.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
315.50
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 77.99M, a decrease of -78.81%. That is a compound annual growth rate of -20.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 77.07M | -17.76% |
| Dec 31, 2024 | 93.71M | -48.18% |
| Dec 29, 2023 | 180.84M | -29.06% |
| Dec 30, 2022 | 254.92M | -28.46% |
| Dec 31, 2021 | 356.33M | -8.65% |
| Dec 31, 2020 | 390.07M | 30.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 94.03B |
| Danel (Adir Yeoshua) | 2.78B |
| Kamada | 1.34B |
| Bait Bakfar | 1.09B |
| SofWave Medical | 1.03B |
| BrainsWay | 994.27M |
| Ilex Medical | 776.90M |
| Novolog (Pharm-Up 1966) | 672.31M |